Neuronetics is trading at $1.97 (+5.45%) in early trading on July 29, 2026, despite a lack of company-specific news, earnings, or regulatory catalysts.
- The move likely reflects broader Healthcare sector strength, which is up 2.56% as investors favor the group amid strong earnings sentiment.
- As a highly volatile small-cap stock, Neuronetics is prone to significant intraday price swings even in the absence of fundamental news drivers.